Could there be a third big pharma acquisition this week? MSD is rumoured to be in talks to buy Revolution Medicines in a deal that could be worth up to $32 billion. The chatter – first reported by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results